2170 Results

People

  1. Busam
    Busam
  2. Marghoob
    Marghoob
  3. Halpern
    Halpern
  4. Houghton
    Houghton
  5. Coit
    Coit
  6. Wolchok
    Wolchok
  7. Old
    Old
  8. Chapman
    Chapman
  9. Postow
    Postow
  10. Dusza
    Dusza

Groups

  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)
  7. Dermatology (393)
  8. Dermatology Service (387)
  9. Melanoma and Immunotherapeutics Service (380)
  10. Population Sciences Research Program (361)
  1. "melanoma"
Formats
  1. Journal Article (1939)
  2. Review (86)
  3. Editorial (32)
  4. Research Letter (28)
  5. Book Section (27)
  6. Conference Paper (19)
  7. Meeting Abstract (12)
  8. Guidelines (11)
  9. Miscellaneous (9)
  10. Correspondence (7)
Groups
  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)

More Groups

People
  1. Klaus Busam (217)
  2. Ashfaq Marghoob (212)
  3. Jedd Wolchok (180)
  4. Allan Halpern (153)
  5. Alan Houghton (138)
  6. Paul Chapman (125)

More People

Years
  1. 2025 (48)
  2. 2024 (94)
  3. 2023 (92)
  4. 2022 (94)
  5. 2021 (63)
  6. 2020 (76)

More Years

Publications
  1. Journal of the American Academy of Dermatology (89)
  2. Annals of Surgical Oncology (65)
  3. Journal of Clinical Oncology (65)
  4. Clinical Cancer Research (56)
  5. Cancer Research (48)
  6. Cancer (45)

More Publications

Publishers
  1. Elsevier Inc. (206)
  2. Springer (184)
  3. Wiley Blackwell (173)
  4. Lippincott Williams & Wilkins (166)
  5. American Association for Cancer Research (141)
  6. Mosby Elsevier (95)

More Publishers

Results (2170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Factors determining long-term antitumor responses to immune checkpoint blockade therapy in melanoma
    Journal Article

    Loo, K.; Smithy, J. W.; Postow, M. A.; Betof Warner, A.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • Evolution in sinonasal mucosal melanoma management
    Review

    Richa, T.; Lee, A.; Cohen, M. A.
    Journal of Neurological Surgery Reports (2022)

    Fulltext@MSK | Save
  • Health care costs for adolescents and young adults with cancer: A Wisconsin community-based hospital study between 2005 and 2020
    Meeting Abstract

    Taparra, K.; Fitzsimmons, A.; Frankki, S.; De Wall, A.; Chino, F.; Peters, A.
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • Response to Rigel et al.
    Correspondence

    Marchetti, M. A.; Dusza, S. W.
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • Ganglioside GD2 enhances the malignant phenotypes of melanoma cells by cooperating with integrins
    Journal Article

    Yesmin, F.; Bhuiyan, R. H.; Ohmi, Y.; Yamamoto, S.; Kaneko, K.; Ohkawa, Y.; Zhang, P.; Hamamura, K.; Cheung, N. K. V.; Kotani, N.; more...
    International Journal of Molecular Sciences (2022)

    Fulltext@MSK | Save
  • Optimizing detection of lymphatic invasion in primary cutaneous melanoma with the use of D2-40 and a paired melanocytic marker
    Journal Article

    Straker, R. J. 3rd; Taylor, L. A.; Neuwirth, M. G.; Sinnamon, A. J.; Shannon, A. B.; Abbott, J.; Miura, J. T.; Chu, E. Y.; Xu, X.; Karakousis, G. C.
    American Journal of Dermatopathology (2022)

    Fulltext@MSK | Save
  • TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
    Journal Article

    Thielmann, C. M.; Matull, J.; Zaremba, A.; Murali, R.; Chorti, E.; Lodde, G.; Jansen, P.; Herbst, R.; Terheyden, P.; Utikal, J.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Analysis of keywords used in internet searches for melanoma information: Observational study
    Journal Article

    Nanda, J. K.; Hay, J. L.; Marchetti, M. A.
    JMIR Dermatology (2021)

    Fulltext@MSK | Save
  • Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
    Journal Article

    García-Silva, S.; Benito-Martín, A.; Nogués, L.; Hernández-Barranco, A.; Mazariegos, M. S.; Santos, V.; Hergueta-Redondo, M.; Ximénez-Embún, P.; Kataru, R. P.; Lopez, A. A.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save